|
|
||||||||
Articles |
Percutaneous transluminal angioplasty was performed in 31 hypertensive patients with primary success in 26 patients (83%). Twenty-three patients had a mean follow-up of 13 months. The cure rate was 30% with a further 26% being improved. However, in the group of patients with lateralizing renal vein renin values, the cure rate rose to 47% with a further 33% improved. Of the eight patients with fibromuscular disease, 83% were normotensive without medication at follow-up; in the 13 patients with atherosclerotic disease, 22% were cured and 44% were classified as improved. Patients with fibromuscular disease and lateralization of renin production are the best candidates for long-term success.
This article has been cited by other articles:
![]() |
T. C. Leertouwer, E. J. Gussenhoven, J. L. Bosch, B. C. van Jaarsveld, L. C. van Dijk, J. Deinum, and A. J. Man in 't Veld Stent Placement for Renal Arterial Stenosis: Where Do We Stand? A Meta-analysis Radiology, July 1, 2000; 216(1): 78 - 85. [Abstract] [Full Text] |
||||
![]() |
H. Ohta, T. Takabatake, Y. Yamamoto, Y.-i. Ishida, H. Hara, Y. Ushiogi, S. Nakamura, M. Kawabata, N. Hashimoto, T. Sasaki, et al. The Long Term Effects of Percutaneous Transluminal Angioplasty for Treating Patients with Renovascular Hypertension: Case Studies Angiology, July 1, 1986; 37(7): 535 - 542. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |